Pinetree Capital Ltd. (TSE:PNP – Get Free Report) insider L6 Holdings Inc. sold 3,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of C$10.10, for a total transaction of C$30,300.00.
L6 Holdings Inc. also recently made the following trade(s):
- On Wednesday, December 11th, L6 Holdings Inc. sold 3,000 shares of Pinetree Capital stock. The stock was sold at an average price of C$11.53, for a total value of C$34,590.00.
- On Monday, December 9th, L6 Holdings Inc. sold 3,000 shares of Pinetree Capital stock. The stock was sold at an average price of C$12.56, for a total value of C$37,680.00.
- On Thursday, December 5th, L6 Holdings Inc. sold 3,076 shares of Pinetree Capital stock. The shares were sold at an average price of C$15.12, for a total value of C$46,506.04.
Pinetree Capital Stock Up 1.5 %
Shares of TSE PNP opened at C$10.10 on Friday. The company has a current ratio of 8.14, a quick ratio of 5.97 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of C$94.84 million, a PE ratio of 7.11 and a beta of 0.60. The firm’s 50-day moving average is C$9.73 and its 200-day moving average is C$7.64. Pinetree Capital Ltd. has a 1 year low of C$3.46 and a 1 year high of C$15.43.
Pinetree Capital Company Profile
Pinetree Capital Ltd. is a venture capital and private equity firm specializing in early, later stage venture, middle market, mature, later stage, turnaround and growth capital investments in micro and small cap companies. The firm prefers to invest in enterprise software, financial and healthcare industries.
Featured Articles
- Five stocks we like better than Pinetree Capital
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Pinetree Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pinetree Capital and related companies with MarketBeat.com's FREE daily email newsletter.